tirzepatide in ghana SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of ECO 2026: tirzepatide shows potential
Description
Semaglutide is recognized for its superior efficacy in reducing the risk of cardiovascular events, making it an attractive option for those concerned about heart health
How tirzepatide works: the GLP-1 and GIP dual agonist Tirzepatide changed the game by adding a second receptor target: glucose-dependent insulinotropic polypeptide (GIP)
The average change in body weight from baseline over 72 weeks was a 22.8 kg reduction (20.2% drop) in the tirzepatide group and a 15.0 kg reduction (13.7% drop) in the semaglutide group
2024;81(4):e413
On the other hand, those taking the 10 mg and 15 mg dosage strengths lost 19.5% and 20.9%, respectively
Step 2: Divide your desired dose by the concentration
